Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Nichols

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2014
Portal vein delivery of viral vectors for gene therapy for hemophiliaAlexandra Sherman, Alexander Schlachterman, Mario Cooper, et al.
Thrombosis Research|November 11, 2006
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and miceLingfei Xu, Manxue Mei, Mark E Haskins, et al.
Molecular Oncology|October 20, 2021
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional stateWen Yan, Chi-Yeh Chung, Tao Xie, et al.
Journal of Translational Medicine|May 3, 2017
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsDavid M Markusic, Timothy C Nichols, Elizabeth P Merricks, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversionJay N Lozier, Amalia Dutra, Evgenia Pak, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
Blood Advances|March 4, 2018
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog modelRobert A French, Benjamin J Samelson-Jones, Glenn P Niemeyer, et al.
Science Translational Medicine|April 8, 2010
A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigsLaura A Maile, Walker H Busby, Timothy C Nichols, et al.
Thrombosis|November 18, 2011
Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studiesTimothy C Nichols, Dwight A Bellinger, Elizabeth P Merricks, et al.
Blood|August 2, 2003
PECAM-1 negatively regulates GPIb/V/IX signaling in murine plateletsVipul Rathore, Michelle A Stapleton, Cheryl A Hillery, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2014
Portal vein delivery of viral vectors for gene therapy for hemophiliaAlexandra Sherman, Alexander Schlachterman, Mario Cooper, et al.
Thrombosis Research|November 11, 2006
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and miceLingfei Xu, Manxue Mei, Mark E Haskins, et al.
Molecular Oncology|October 20, 2021
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional stateWen Yan, Chi-Yeh Chung, Tao Xie, et al.
Journal of Translational Medicine|May 3, 2017
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsDavid M Markusic, Timothy C Nichols, Elizabeth P Merricks, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversionJay N Lozier, Amalia Dutra, Evgenia Pak, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
Blood Advances|March 4, 2018
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog modelRobert A French, Benjamin J Samelson-Jones, Glenn P Niemeyer, et al.
Science Translational Medicine|April 8, 2010
A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigsLaura A Maile, Walker H Busby, Timothy C Nichols, et al.
Thrombosis|November 18, 2011
Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studiesTimothy C Nichols, Dwight A Bellinger, Elizabeth P Merricks, et al.
Blood|August 2, 2003
PECAM-1 negatively regulates GPIb/V/IX signaling in murine plateletsVipul Rathore, Michelle A Stapleton, Cheryl A Hillery, et al.
Pageof 11